Nusse Roeland 4
4 · BIO-TECHNE Corp · Filed Oct 31, 2022
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Nusse Roeland
Director
Transactions
- Award
Common Stock
2022-10-27+338→ 7,297 total - Award
Stock Options (Right to Buy)
2022-10-27+865→ 865 totalExercise: $295.77Exp: 2032-10-27→ Common Stock (865 underlying)
Holdings
- 3,125
Stock Options (Right to Buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 2,011
Stock Options (Right to Buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying) - 1,507
Stock Options (Right to Buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying) - 3,985
Stock Options (Right to Buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-27→ Common Stock (3,985 underlying) - 1,898
Stock Options (Right to Buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Commo Stock (1,898 underlying) - 4,000
Stock Options (Right to Buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 4,000
Stock Options (Right to Buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Options (Right to Buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 633
Stock Options (Right to Buy)
Exercise: $515.24From: 2022-10-27Exp: 2031-10-28→ Common Stock (633 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.